Bridgeway Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-53,000
| Closed | -$792K | – | 1470 |
|
|
2022
Q4 | $792K | Hold |
53,000
| – | – | 0.02% | 789 |
|
|
2022
Q3 | $436K | Hold |
53,000
| – | – | 0.01% | 921 |
|
|
2022
Q2 | $348K | Buy |
+53,000
| New | +$257K | 0.01% | 963 |
|
|
2020
Q3 | – | Sell |
-34,300
| Closed | -$177K | – | 1403 |
|
|
2020
Q2 | $177K | Buy |
+34,300
| New | +$216K | ﹤0.01% | 1169 |
|
|
2019
Q1 | – | Sell |
-34,646
| Closed | -$554K | – | 1434 |
|
|
2018
Q4 | $554K | Hold |
34,646
| – | – | 0.01% | 967 |
|
|
2018
Q3 | $1.15M | Hold |
34,646
| – | – | 0.01% | 829 |
|
|
2018
Q2 | $783K | Hold |
34,646
| – | – | 0.01% | 975 |
|
|
2018
Q1 | $1M | Hold |
34,646
| – | – | 0.01% | 839 |
|
|
2017
Q4 | $967K | Hold |
34,646
| – | – | 0.01% | 855 |
|
|
2017
Q3 | $1.26M | Sell |
34,646
-11,450
| -25% | -$354K | 0.01% | 762 |
|
|
2017
Q2 | $1.02M | Hold |
46,096
| – | – | 0.01% | 817 |
|
|
2017
Q1 | $272K | Hold |
46,096
| – | – | ﹤0.01% | 1227 |
|
|
2016
Q4 | $249K | Sell |
46,096
-5,309
| -10% | -$35.4K | ﹤0.01% | 1268 |
|
|
2016
Q3 | $458K | Hold |
51,405
| – | – | 0.01% | 1125 |
|
|
2016
Q2 | $494K | Buy |
51,405
+20,000
| +64% | +$193K | 0.01% | 1056 |
|
|
2016
Q1 | $289K | Hold |
31,405
| – | – | ﹤0.01% | 1223 |
|
|
2015
Q4 | $396K | Buy |
31,405
+11,955
| +61% | +$142K | 0.01% | 1135 |
|
|
2015
Q3 | $235K | Hold |
19,450
| – | – | ﹤0.01% | 1280 |
|
|
2015
Q2 | $338K | Hold |
19,450
| – | – | 0.01% | 1215 |
|
|
2015
Q1 | $282K | Buy |
19,450
+1,450
| +8% | +$15.8K | 0.01% | 1272 |
|
|
2014
Q4 | $151K | Hold |
18,000
| – | – | ﹤0.01% | 1341 |
|
|
2014
Q3 | $200K | Buy |
18,000
+15,000
| +500% | +$191K | 0.01% | 1338 |
|
|
2014
Q2 | $55K | Buy |
+3,000
| New | +$39K | ﹤0.01% | 1421 |
|
|
2014
Q1 | – | Sell |
-58,000
| Closed | -$1.06M | – | 1480 |
|
|
2013
Q4 | $1.06M | Hold |
58,000
| – | – | 0.03% | 717 |
|
|
2013
Q3 | $1.2M | Buy |
58,000
+14,000
| +32% | +$321K | 0.04% | 649 |
|
|
2013
Q2 | $1.1M | Buy |
+44,000
| New | +$1.88M | 0.04% | 587 |
|
Bridgeway Capital Management's AVEO Position: Q1 2023 in Review
Bridgeway Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 53,000 shares — an estimated $792K sold.
Bridgeway Capital Management first reported a position in AVEO in Q2 2013 and held it in 26 quarters. The position peaked at $1.26M in Q3 2017. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Bridgeway Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Bridgeway Capital Management sold 53,000 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $792K.
- Bridgeway Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 26 quarters.
- Bridgeway Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $1.26M in Q3 2017.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Bridgeway Capital Management's 13F filing for Q1 2023, filed 15 May 2023.